Literature DB >> 13172286

Leukemia in atomic bomb survivors. II. Observations on early phases of leukemia.

W C MOLONEY, R D LANGE.   

Abstract

Entities:  

Keywords:  ATOMIC WARFARE; BLOOD; LEUKEMIA/blood in

Mesh：

Year:  1954        PMID： 13172286

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

Review 1.  THE LEUKEMIAS.

Authors:  N L PETRAKIS
Journal:  Calif Med       Date:  1964-07

2.  [Enzyme pathology of the blood cells].

Authors:  K U BLUM
Journal:  Blut       Date:  1962-06

3.  [Research on the amino acid metabolism of human leukocytes].

Authors:  K SCHREIER; E ZOELLER; K THOMAS; W HART; V STOECKLE; E BERGMANN
Journal:  Klin Wochenschr       Date:  1961-06-01

4.  Carcinoma of the stomach in Hiroshima, Japan.

Authors:  E S MURPHY; A YASUDA
Journal:  Am J Pathol       Date:  1958 May-Jun       Impact factor: 4.307

Review 5.  Systematic review of pre-clinical chronic myeloid leukaemia.

Authors:  Jew Win Kuan; Anselm Ting Su; Chooi Fun Leong; Motomi Osato; Goro Sashida
Journal:  Int J Hematol       Date:  2018-09-14       Impact factor: 2.490

6.  [Late lesions following thorotrast use].

Authors:  H Gaus; M Gülzow; G Meyer-Hofmann
Journal:  Klin Wochenschr       Date:  1966-01-01

7.  Leukaemia in Nagasaki atomic bomb survivors from 1945 through 1959.

Authors:  M TOMONAGA
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

8.  Formaldehyde Exposure and Mortality Risks From Acute Myeloid Leukemia and Other Lymphohematopoietic Malignancies in the US National Cancer Institute Cohort Study of Workers in Formaldehyde Industries.

Authors:  Harvey Checkoway; Linda D Dell; Paolo Boffetta; Alexa E Gallagher; Lori Crawford; Peter Sj Lees; Kenneth A Mundt
Journal:  J Occup Environ Med       Date:  2015-07       Impact factor: 2.162

9.  Peak Exposures in Epidemiologic Studies and Cancer Risks: Considerations for Regulatory Risk Assessment.

Authors:  Harvey Checkoway; Peter S J Lees; Linda D Dell; P Robinan Gentry; Kenneth A Mundt
Journal:  Risk Anal       Date:  2019-03-29       Impact factor: 4.000
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.